Euroapi Future Growth
Future criteria checks 3/6
Euroapi is forecast to grow earnings and revenue by 85.2% and 1.5% per annum respectively. EPS is expected to grow by 85.3% per annum. Return on equity is forecast to be 2.7% in 3 years.
Key information
85.2%
Earnings growth rate
85.3%
EPS growth rate
Pharmaceuticals earnings growth | 23.0% |
Revenue growth rate | 1.5% |
Future return on equity | 2.7% |
Analyst coverage | Low |
Last updated | 23 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,004 | 33 | 46 | 133 | 4 |
12/31/2025 | 969 | -12 | 3 | 117 | 4 |
12/31/2024 | 917 | -82 | 72 | 178 | 3 |
12/31/2023 | 1,019 | -190 | -161 | 5 | N/A |
9/30/2023 | 1,006 | -79 | -133 | 4 | N/A |
6/30/2023 | 994 | 31 | -105 | 3 | N/A |
3/31/2023 | 987 | 8 | -87 | 24 | N/A |
12/31/2022 | 981 | -15 | -69 | 45 | N/A |
9/30/2022 | 962 | -3 | -99 | 46 | N/A |
6/30/2022 | 944 | 10 | -129 | 47 | N/A |
3/31/2022 | 918 | 1 | -96 | 59 | N/A |
12/31/2021 | 893 | -8 | -64 | 72 | N/A |
12/31/2020 | 945 | -6 | 8 | 97 | N/A |
12/31/2019 | 916 | 3 | -47 | 35 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EAPI.F is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).
Earnings vs Market: EAPI.F is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: EAPI.F is expected to become profitable in the next 3 years.
Revenue vs Market: EAPI.F's revenue (1.5% per year) is forecast to grow slower than the US market (8.2% per year).
High Growth Revenue: EAPI.F's revenue (1.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: EAPI.F's Return on Equity is forecast to be low in 3 years time (2.7%).